StonvexLoading…
StonvexCore line items from AGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.61B | $1.60B | $1.39B | $716.85M |
Operating Income | $255.71M | $258.10M | $253.10M | $225.68M |
Net Income | $207.41M | $207.19M | $200.00M | $178.14M |
EPS (Diluted) | $16.62 | $16.44 | $15.81 | $13.87 |
Total Assets | $35.37B | $31.32B | $29.52B | $27.33B |
Total Liabilities | $33.65B | $29.84B | $28.11B | $26.06B |
Cash & Equivalents | $931.07M | $1.02B | $888.71M | $861.00M |
Free Cash Flow OCF − CapEx | $80.06M | $607.37M | $375.80M | $809.27M |
Shares Outstanding | 10.98M | 10.97M | 10.94M | 10.88M |